Dimensional Fund Advisors LP Tg Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $684,981 - $1.27 Million
-31,450 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$32.5 - $48.96 $1.75 Million - $2.63 Million
-53,803 Reduced 63.11%
31,450 $1.22 Million
Q1 2021

May 14, 2021
BUY
$41.61 - $54.3 $3.32 Million - $4.33 Million
79,765 Added 1453.44%
85,253 $4.11 Million
Q4 2020

Feb 25, 2021
BUY
$25.27 - $54.9 $138,681 - $301,291
5,488 New
5,488 $285,000

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.03B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email